e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Acute exacerbations of COPD: aetiology and therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Induced sputum cytology at different etiology of exacerbation of chronic obstructive bronchitis
E. B. Bukreeva, S. V. Nesterovich, E. A. Dementyeva, T. G. Melnik, L. V. Gudkova, E. A. Gereng, I. I. Ivanchuk (Tomsk, Russia)
Source:
Annual Congress 2002 - Acute exacerbations of COPD: aetiology and therapy
Session:
Acute exacerbations of COPD: aetiology and therapy
Session type:
Thematic Poster Session
Number:
3365
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. B. Bukreeva, S. V. Nesterovich, E. A. Dementyeva, T. G. Melnik, L. V. Gudkova, E. A. Gereng, I. I. Ivanchuk (Tomsk, Russia). Induced sputum cytology at different etiology of exacerbation of chronic obstructive bronchitis. Eur Respir J 2002; 20: Suppl. 38, 3365
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Exacerbation aetiology and inflammation markers in chronic obstructive bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 252s
Year: 2002
Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis
Source: Eur Respir J 2012; 39: 1354-1360
Year: 2012
Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies
Source: Eur Respir J 2008; 31: 70-77
Year: 2008
Diagnosing COPD: distinguishing between emphysema and chronic bronchitis
Source: International Congress 2015 – ME1 Diagnosing COPD
Year: 2015
Oropharyngeal and sputum microbiome dynamics with the same pattern following exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
Definition and aetiology of infective exacerbations of COPD
Source: Eur Respir Monogr 2013; 60: 58-67
Year: 2013
Sputum rheology and bacteriology in stable and exacerbated chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020
Microbiological screening infectious exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Resolution of bronchial inflammation during exacerbations of chronic bronchitis relate to changes in bacteriology.
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Source: Eur Respir J 2001; 17: 1112-1119
Year: 2001
Cell composition of induced sputum of patients with bronchial asthma(BA) and chronic obstructive bronchitis (COB)
Source: Eur Respir J 2001; 18: Suppl. 33, 368s
Year: 2001
Sputum microbiome richness is decreased in patients treated for acute exacerbations of eosinophilic chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Acute reversibility of airflow limitation and sputum eosinophilia in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 579s
Year: 2004
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Bronchial biopsy characteristics at different etiology of COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 407s
Year: 2005
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design
Source: Eur Respir J 2006; 27: 293-299
Year: 2006
Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002
Dynamics of the inflammatory process by determining the IL-6 content in bronchoalveolar fluid in chronic bronchitis and chronic bronchitis complicated by secondary bronchiectasis
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Source: Eur Respir J 2002; 20: 9S-19S
Year: 2002
Bacterial infection in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept